# US 2022/0032257 A1 · Screening assays and methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0032257 A1
- Document ID: US20220032257A1
- Status: Published application
- Kind: A1
- Application number: 17/479,515
- Filed: 2021-09-20
- Published: 2022-02-03
- Earliest claimed: 2005-09-16
- Assignees: President and Fellows of Harvard College
- Applicants: President and Fellows of Harvard College
- Inventors: J. Christopher Love; Hidde L. Ploegh; Jehnna Ronan
- Web page: https://patentgrep.com/patent/US20220032257A1

## CPC

- B01J 19/0046: {Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays (synthesis methods per se C40B50/00)}
- B01L 3/50853: {with covers or lids (closures for test tubes B01L3/50825)}
- B82Y 30/00: Nanotechnology for materials or surface science, e.g. nanocomposites
- G01N 21/6452: {Individual samples arranged in a regular 2D-array, e.g. multiwell plates}
- G01N 33/505: {involving T-cells}
- G01N 33/5052: {involving B-cells}
- G01N 33/531: Production of immunochemical test materials
- G01N 33/543: with an insoluble carrier for immobilising immunochemicals
- G01N 33/54366: {Apparatus specially adapted for solid-phase testing}
- G01N 33/577: involving monoclonal antibodies {binding reaction mechanisms characterised by the use of monoclonal antibodies (G01N33/5302 - G01N33/576 take precedence)}
- G01N 33/6854: {Immunoglobulins}
- B01J 2219/00317: Microwell devices, i.e. having large numbers of wells
- B01J 2219/00527: Sheets
- B01J 2219/00585: Parallel processes
- B01J 2219/00675: In-situ synthesis on the substrate
- B01J 2219/00722: Nucleotides
- B01J 2219/00725: Peptides
- B01J 2219/00734: Lipids
- B01J 2219/0074: Biological products
- B01L 2200/025: Align devices or objects to ensure defined positions relative to each other
- B01L 2200/12: Specific details about manufacturing devices
- B01L 2300/0819: Microarrays; Biochips
- B01L 2300/12: Specific details about materials
- Y10S 436/809: Multifield plates or multicontainer arrays
- Y10T 436/24: Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

Screening assays and methods of performing such assays are provided. In certain examples, the assays and methods may be designed to determine whether or not two or more species can associate with each other. In some examples, the assays and methods may be used to determine if a known antigen binds to an unknown monoclonal antibody.

## Claims

### Claim 1

A printed microarray of unknown cell-derived products, each position of said array comprising a deposit corresponding to a composition of a single cell, said deposit being less than 100 micrometers in diameter.

### Claim 2 (depends on 1)

The microarray of claim 1, wherein said deposit is a secreted cell-derived product selected from the group consisting of an antibody, cytokine, chemokine, and inflammatory mediator.

### Claim 3 (depends on 1)

The microarray of claim 1, wherein said microarray comprises a capture ligand for a class of secreted products.

### Claim 4 (depends on 3)

The microarray of claim 3, wherein said capture ligand binds to a single immunoglobulin isotype.
